Methods of use of emulsion formulations of an NK-1 receptor antagonist
US-12115255-B2 · Oct 15, 2024 · US
This page is not indexed by search engines while we improve data quality.
Heron Therapeutics Inc — Physics
Heron Therapeutics Inc holds 15 patents in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Heron Therapeutics Inc |
| Technology | Physics |
| Patents in slice | 15 |
| Recent patents in slice | 7 |
| First year | 2017 |
| Last year | 2024 |
Representative patents
Notable publications linking Heron Therapeutics Inc to Physics.
Methods of use of emulsion formulations of an NK-1 receptor antagonist
US-12115255-B2 · Oct 15, 2024 · US
Methods of use of emulsion formulations of an NK-1 receptor antagonist
US-12115255-B2 · Oct 15, 2024 · US
Methods of use of emulsion formulations of an NK-1 receptor antagonist
US-12115255-B2 · Oct 15, 2024 · US
Methods of use of emulsion formulations of an NK-1 receptor antagonist
US-12115255-B2 · Oct 15, 2024 · US
Recent filings
Latest patents from Heron Therapeutics Inc in Physics.
Methods of use of emulsion formulations of an NK-1 receptor antagonist
US-12115255-B2 · Oct 15, 2024 · US
Methods of use of emulsion formulations of an NK-1 receptor antagonist
US-12115255-B2 · Oct 15, 2024 · US
Methods of use of emulsion formulations of an NK-1 receptor antagonist
US-12115255-B2 · Oct 15, 2024 · US
Methods of use of emulsion formulations of an NK-1 receptor antagonist
US-12115255-B2 · Oct 15, 2024 · US
Methods of use of emulsion formulations of an NK-1 receptor antagonist
US-12115255-B2 · Oct 15, 2024 · US
Related pages
Navigate to parent entity pages.